Semax - Research Peptide

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment 4-7, developed and extensively studied in neuropharmacological research. It is one of the most researched neuropeptides in academic literature, with a substantial body of preclinical studies examining its role in neurotrophic signalling, cognitive function modelling, and neuroprotective mechanisms.

Compound Details

• Sequence: Met-Glu-His-Phe-Pro-Gly-Pro

• Molecular Weight: 813.9 g/mol

• CAS Number: 80714-61-0

• Purity: >99% (HPLC verified)

• Form: Lyophilised powder

• Available sizes: 5mg, 10mg

Research Background

Academic studies have investigated Semax's involvement in brain-derived neurotrophic factor (BDNF) upregulation, nerve growth factor (NGF) signalling pathways, and dopaminergic system modulation. It has also been studied in the context of neurological recovery models, cerebral blood flow regulation, and cognitive performance research. Semax has been the subject of significant academic interest in Eastern European neuroscience research for several decades. All research has been conducted in controlled in vitro and animal model settings.

Storage & Handling

Once reconstituted, store at 4°C. For laboratory research use only.

Quality Assurance

Every batch of Semax supplied by Biomaxx is independently third-party tested and HPLC verified to confirm >99% purity. A Certificate of Analysis (CoA) is available upon request.

For research purposes only. Not for human consumption. Must be handled by qualified researchers in a controlled laboratory environment.